EUVIMEDEUVIMED entdecken
Open Access

Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons

Viktor Yarotskyy iD, Rachel M Schmitt iD, Hannah J Goudsward iD, Sara R Nass iD, Kyle Harbour iD, A Rory McQuiston iD, Pamela E Knapp iD, Kurt F Hauser iD

Journal of Neurophysiology · 01.02.2026 · 135 (2) · 457-474

DOI: 10.1152/jn.00427.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurophysiology, erschienen am 01.02.2026. Verfasst von Viktor Yarotskyy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States. Hauptthemen laut MEDLINE: Fentanyl, Xylazine, Receptors, Dopamine D2, Corpus Striatum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute on Drug Abuse (NIDA), NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute fentanyl and xylazine co-exposure increased the excitability of striatal dopamine receptor-(D2) expressing medium spiny neurons (MSNs) to lower intensity currents, whereas higher intensity stimuli decreased firing rates and increased the initial momentary frequency of action potentials. Fentanyl or xylazine exposure decreased D2 MSN excitability at higher current intensities with near additive decreases following co-exposure. Fentanyl and xylazine interact to selectively alter D2 MSN excitability potentially contributing to dystonia and enhancing fentanyl’s reinforcing properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylXylazineReceptors, Dopamine D2Corpus StriatumAdrenergic alpha-2 Receptor AgonistsAnalgesics, OpioidDopaminergic NeuronsAnimalsMaleAction PotentialsMiceMedium Spiny Neurons

Stichwörter der Autor:innen

adrenergic receptorfentanylopioidsstriatumxylazine

Substanzen

FentanylXylazineReceptors, Dopamine D2Adrenergic alpha-2 Receptor AgonistsAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
  • Department of Neuroscience and Anatomy, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.
  • Institute for Drug and Alcohol Studies, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States.

ORCID-Profile: Viktor Yarotskyy, Rachel M Schmitt, Hannah J Goudsward, Sara R Nass, Kyle Harbour, A Rory McQuiston, Pamela E Knapp, Kurt F Hauser

Förderung

  • HHS | NIH | National Institute on Drug Abuse (NIDA)
  • NIDA NIH HHS

Zitieren

APA

Yarotskyy, V., Schmitt, R. M., Goudsward, H. J., Nass, S. R., Harbour, K., McQuiston, A. R., Knapp, P. E., & Hauser, K. F. (2026). Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons. Journal of Neurophysiology, 135(2), 457-474. https://doi.org/10.1152/jn.00427.2025

Vancouver

Yarotskyy V, Schmitt RM, Goudsward HJ, Nass SR, Harbour K, McQuiston AR, et al. Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons. Journal of Neurophysiology. 2026;135(2):457-474. doi:10.1152/jn.00427.2025

BibTeX
@article{Yarotskyy2026,
  author = {Yarotskyy, Viktor and Schmitt, Rachel M and Goudsward, Hannah J and Nass, Sara R and Harbour, Kyle and McQuiston, A Rory and Knapp, Pamela E and Hauser, Kurt F},
  title = {Acute fentanyl and xylazine co-exposure uniquely increase the excitability of dopamine type 2 receptor-expressing striatal medium spiny neurons},
  journal = {Journal of Neurophysiology},
  year = {2026},
  volume = {135},
  number = {2},
  pages = {457--474},
  doi = {10.1152/jn.00427.2025}
}
Kostenlos starten →